Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 090227
Company: SANDOZ
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
AMOXICILLIN AND CLAVULANATE POTASSIUM AMOXICILLIN; CLAVULANATE POTASSIUM 1GM;EQ 62.5MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
04/21/2010 ORIG-1 Approval Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/090227s000ltr.pdf
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
01/05/2016 SUPPL-8 Labeling-Package Insert

Label is not available on this site.

01/16/2015 SUPPL-7 Labeling-Package Insert

Label is not available on this site.

09/04/2012 SUPPL-4 Labeling-Package Insert

Label is not available on this site.

AMOXICILLIN AND CLAVULANATE POTASSIUM

TABLET, EXTENDED RELEASE;ORAL; 1GM;EQ 62.5MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AMOXICILLIN AND CLAVULANATE POTASSIUM AMOXICILLIN; CLAVULANATE POTASSIUM 1GM;EQ 62.5MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 090227 SANDOZ
AUGMENTIN XR AMOXICILLIN; CLAVULANATE POTASSIUM 1GM;EQ 62.5MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription Yes AB 050785 DR REDDYS LABS INC

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English